Department of Neurosurgery, Yale School of Medicine, New Haven, CT, 06510, USA.
Division of Nephrology and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, and Department of Medicine, Harvard Medical School, Boston, MA, USA.
Childs Nerv Syst. 2021 Nov;37(11):3341-3353. doi: 10.1007/s00381-021-05255-z. Epub 2021 Jun 23.
Reparative inflammation is an important protective response that eliminates foreign organisms, damaged cells, and physical irritants. However, inappropriately triggered or sustained inflammation can respectively initiate, propagate, or prolong disease. Post-hemorrhagic (PHH) and post-infectious hydrocephalus (PIH) are the most common forms of hydrocephalus worldwide. They are treated using neurosurgical cerebrospinal fluid (CSF) diversion techniques with high complication and failure rates. Despite their distinct etiologies, clinical studies in human patients have shown PHH and PIH share similar CSF cytokine and immune cell profiles. Here, in light of recent work in model systems, we discuss the concept of "inflammatory hydrocephalus" to emphasize potential shared mechanisms and potential therapeutic vulnerabilities of these disorders. We propose that this change of emphasis could shift our thinking of PHH and PIH from a framework of life-long neurosurgical disorders to that of preventable conditions amenable to immunomodulation.
修复性炎症是一种重要的保护反应,可消除外来生物、受损细胞和物理刺激物。然而,不适当触发或持续的炎症可分别引发、传播或延长疾病。出血后(PHH)和感染后脑积水(PIH)是全世界最常见的脑积水形式。它们采用神经外科脑脊液(CSF)分流技术进行治疗,但并发症和失败率较高。尽管它们的病因不同,但对人类患者的临床研究表明,PHH 和 PIH 具有相似的 CSF 细胞因子和免疫细胞特征。在这里,鉴于模型系统中的最新研究,我们讨论了“炎症性脑积水”的概念,以强调这些疾病的潜在共同机制和潜在治疗弱点。我们提出,这种重点的转变可以将我们对 PHH 和 PIH 的思维从一种终身性神经外科疾病框架转变为可预防的、可进行免疫调节的疾病框架。